HAE

MKT CAP:$3B

Haemonetics Corporation

Market Cap

$3B

Healthcare·Medical Devices·🇺🇸 United States·NYSE

Healthcare·Medical Devices·🇺🇸·NYSE

Stock Price

$74.88-$5.10 (-6.38%)

Jun 8, 2026

52W High $87.1652W Low $47.67

Company Details

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor man...

CEO

—

IPO Date

May 9, 1991

Website

www.haemonetics.com

Key Metrics TTM

Revenue

$1.3B

-2.0% YoY

Net Income

$97M

EPS (Diluted)

Free Cash Flow

$260M

Revenue / Share

$28.86

Gross Margin

57.3%

Operating Margin

18.2%

Net Margin

7.3%

FCF Margin

19.5%

P/S

2.3x

P/E

31.4x

Earnings Reports

Q1 2027

Aug 6, 2026

PENDING

FY 2026

May 20, 2026

$1.3B-2.0%

Q4 2026

May 20, 2026

$346M+4.8%

Q3 2026

Feb 5, 2026

$339M-2.7%

Q2 2026

Nov 6, 2025

$327M-5.3%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee